Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
57.93
-0.41 (-0.70%)
Sep 8, 2025, 11:44 AM CST
SHE:002294 Revenue
Shenzhen Salubris Pharmaceuticals had revenue of 1.07B CNY in the quarter ending June 30, 2025, with 12.30% growth. This brings the company's revenue in the last twelve months to 4.10B, up 10.12% year-over-year. In the year 2024, Shenzhen Salubris Pharmaceuticals had annual revenue of 4.01B with 19.22% growth.
Revenue (ttm)
4.10B
Revenue Growth
+10.12%
P/S Ratio
15.86
Revenue / Employee
1.14M
Employees
3,596
Market Cap
65.04B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.01B | 646.89M | 19.22% |
Dec 31, 2023 | 3.37B | -116.67M | -3.35% |
Jan 1, 2023 | 3.48B | 423.62M | 13.85% |
Jan 1, 2022 | 3.06B | 319.83M | 11.68% |
Dec 31, 2020 | 2.74B | -1.73B | -38.74% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Shanghai United Imaging Healthcare | 10.98B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |